Repligen putting idle assets to work

Even as it's downsizing to conserve capital, Repligen Corp. is trying to put its idle assets to work to bring in more revenue by taking advantage of changes occurring throughout the biotech industry.

Downsizing typically creates excess capacity in several areas, including manufacturing and facility space. But

Read the full 489 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers